Galera Therapeutics (NASDAQ:GRTX) Target Lowered by Citigroup Inc. to $11.00

StockMarketDaily.co reports: stock has undergone multiple analysts rating changes in the recent past.  stock Target Lowered by   Citigroup Inc. on 10/21/2021. In a note to investors, the firm issued a new target price of $11.00. The analysts previously had $21.00 target price.

View More Galera Therapeutics (NASDAQ:GRTX) Target Lowered by Citigroup Inc. to $11.00

Galera Therapeutics (NASDAQ:GRTX) Downgraded by HC Wainwright to Neutral

Galera Therapeutics} stock has undergone multiple analysts rating changes in the recent past.  Galera Therapeutics Downgraded by HC Wainwright on 10/20/2021. In a note to investors, the firm issued a new rating of Neutral. The analysts previously had rating of Buy.

View More Galera Therapeutics (NASDAQ:GRTX) Downgraded by HC Wainwright to Neutral